WIDEX MOMENT ™ Hearing Aids Named Digital Trends ‘Tech for Change 2021’ Award Winner

January 21, 2021

Widex Inc. today announced that it has been recognized by Digital Trends Media Group with a Tech for Change Award at CES 2021 for its WIDEX MOMENT™ hearing aids. Recipients were selected based on innovations intended to make the world a better place, as displayed during CES.

Digital Trends is one of the world’s most well-respected consumer technology publications, and is widely viewed as the authoritative voice promoting the technologies influencing and impacting consumers across the globe.

WIDEX MOMENT was selected for having pioneered the first digital hearing aid to incorporate dual artificial intelligence engines to improve real-time listening. Furthermore, the WIDEX MOMENT leverages ZeroDelay™ technology to reduce the standard sound delay from 7-10 milliseconds seconds to just 0.5 milliseconds to give people with hearing loss the most natural hearing experience available.

“Hearing aids have historically delivered a ‘tinny’, tube-like sound due to the delay in digital sound processing; as the leader in natural sound, Widex could not stand for this,” stated Søren Hvidberg Nielsen, President of Widex US. “Our engineers have worked tirelessly for five years to overcome this technical challenge, and with our breakthrough WIDEX MOMENT hearing aids we’ve now succeeded.”

Continued Nielsen, “These intelligent devices go far beyond simply boosting speech perception, offering wearers a true-to-life sound experience that’s been elusive until now. We are honored that Digital Trends Media Group recognized WIDEX MOMENT as an innovative, class-leading wearable and wellness device designed to make the world a better place through natural sound for all.”

Widex has pioneered the use of artificial intelligence to create a more personalized sound experience, which in turn leads to higher wearer acceptance and usage. WIDEX MOMENT leverages SoundSense Learn, an AI-based technology, to personalize hearing aid settings in two ways.

First, WIDEX MOMENT learns how users prefer to hear their surroundings by analyzing settings and guiding them through a series of A-B comparisons. Second, an advanced AI-algorithm draws from millions of user settings stored in the cloud to help personalize the listening experience.

Furthermore, WIDEX MOMENT also includes the PureSound™ ZeroDelay™ technology, a groundbreaking parallel processing path that all but eliminates latency, resulting in a more natural sound without the “tinny” distortions associated with other hearing aids.

The net result of these two breakthrough technologies is a more perfect, natural sound that’s uniquely and automatically tailored to each wearer’s listening preferences and profile.

Digital Trends Media Group’s Tech for Change Awards are part of the company’s Tech for Change Series that focuses on innovations in technology that directly impact well-being to make the world a better place.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.